{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:35:53Z","timestamp":1791156953905,"version":"4.1.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.canlet.2010.10.017","type":"journal-article","created":{"date-parts":[[2010,11,20]],"date-time":"2010-11-20T09:34:40Z","timestamp":1290245680000},"page":"7-16","source":"Crossref","is-referenced-by-count":32,"title":["DNA methylation in thoracic neoplasms"],"prefix":"10.1016","volume":"301","author":[{"given":"Chen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangliang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2010.10.017_b0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2010.10.017_b0010","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMra035010","article-title":"Esophageal cancer","volume":"349","author":"Enzinger","year":"2003","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2010.10.017_b0015","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/1097-0142(19940715)74:2<542::AID-CNCR2820740203>3.0.CO;2-1","article-title":"Controversies surrounding the subclassification of thymoma","volume":"74","author":"Shimosato","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1066896909334126","article-title":"The correlation of the World Health Organization histologic classification of thymic epithelial tumors and its prognosis: a clinicopathologic study of 108 patients from China","volume":"17","author":"Honglin","year":"2009","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2010.10.017_b0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pneumo.2009.12.004","article-title":"Epithelial tumours of the thymus","volume":"66","author":"Thomas","year":"2010","journal-title":"Rev. Pneumol. Clin."},{"key":"10.1016\/j.canlet.2010.10.017_b0030","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.athoracsur.2005.03.093","article-title":"Prognostic factors in thymic epithelial tumors undergoing complete resection","volume":"80","author":"Zisis","year":"2005","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.canlet.2010.10.017_b0035","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.athoracsur.2005.05.058","article-title":"Surgical management of thymic epithelial tumors: a retrospective review of 204 cases","volume":"80","author":"Fang","year":"2005","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.canlet.2010.10.017_b0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1586\/ers.09.14","article-title":"Caution: screening for lung cancer","volume":"3","author":"Midthun","year":"2009","journal-title":"Expert. Rev. Respir. Med."},{"key":"10.1016\/j.canlet.2010.10.017_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjc.6605660","article-title":"Lung cancer screening","author":"Pastorino","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.gtc.2009.01.014","article-title":"Screening, surveillance, and prevention for esophageal cancer","volume":"38","author":"Tomizawa","year":"2009","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.canlet.2010.10.017_b0055","first-page":"718","article-title":"Thoracoscopic surgery","volume":"62","author":"Kaneko","year":"2009","journal-title":"Kyobu Geka"},{"key":"10.1016\/j.canlet.2010.10.017_b0060","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/carcin\/22.8.1119","article-title":"Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention","volume":"22","author":"Chen","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2010.10.017_b0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4161\/epi.3.4.6508","article-title":"A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis","volume":"3","author":"Arasaradnam","year":"2008","journal-title":"Epigenetics"},{"key":"10.1016\/j.canlet.2010.10.017_b0070","first-page":"3","article-title":"Surfactant protein DNA methylation: a new entrant in the field of lung cancer diagnostics? (Review)","volume":"21","author":"Vaid","year":"2009","journal-title":"Oncol Rep."},{"key":"10.1016\/j.canlet.2010.10.017_b0075","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/07357900701561131","article-title":"Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma","volume":"25","author":"Long","year":"2007","journal-title":"Cancer Invest."},{"key":"10.1016\/j.canlet.2010.10.017_b0080","doi-asserted-by":"crossref","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B","volume":"104","author":"Fabbri","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.10.017_b0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/157488706776876490","article-title":"Review: recent clinical trials in epigenetic therapy","volume":"1","author":"Oki","year":"2006","journal-title":"Rev. Recent Clin. Trials"},{"key":"10.1016\/j.canlet.2010.10.017_b0090","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1017\/S1462399410001559","article-title":"DNA methylation profiling in cancer","volume":"12","author":"Kondo","year":"2010","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.canlet.2010.10.017_b0095","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1038\/sj.onc.1205651","article-title":"DNA methylation in cancer: too much, but also too little","volume":"21","author":"Ehrlich","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2010.10.017_b0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1634\/stemcells.2006-0383","article-title":"Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells","volume":"25","author":"Gan","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.canlet.2010.10.017_b0105","article-title":"Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review","author":"Shima","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0110","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1002\/ijc.21740","article-title":"Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer","volume":"118","author":"Deng","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1025806911782","article-title":"Epigenetic changes in colorectal cancer","volume":"23","author":"Kondo","year":"2004","journal-title":"Cancer Metast. Rev."},{"key":"10.1016\/j.canlet.2010.10.017_b0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.lungcan.2004.05.003","article-title":"Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer","volume":"46","author":"Tomizawa","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0125","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/cncr.23113","article-title":"Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features","volume":"110","author":"Kim","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0130","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1158\/1078-0432.CCR-05-0859","article-title":"The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer","volume":"11","author":"Matsuzaki","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.1083557","article-title":"Chromosomal instability and tumors promoted by DNA hypomethylation","volume":"300","author":"Eden","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.10.017_b0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000015590","article-title":"DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients","volume":"89","author":"Tuck-Muller","year":"2000","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.canlet.2010.10.017_b0145","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ijc.21807","article-title":"Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues","volume":"119","author":"Arai","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2004.12.031","article-title":"An association of DNMT3b protein expression with P16INK4a promoter hypermethylation in non-smoking female lung cancer with human papillomavirus infection","volume":"226","author":"Lin","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2010.10.017_b0155","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/07357900802620869","article-title":"Aberrant DNA methylation in thymic epithelial tumors","volume":"27","author":"Chen","year":"2009","journal-title":"Cancer Invest."},{"key":"10.1016\/j.canlet.2010.10.017_b0160","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00018-009-0015-5","article-title":"DNA hypomethylation in the origin and pathogenesis of human diseases","volume":"66","author":"Pogribny","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.canlet.2010.10.017_b0165","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.0710735105","article-title":"High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer","volume":"105","author":"Rauch","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2010.10.017_b0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/5947","article-title":"Cancer epigenetics comes of age","volume":"21","author":"Jones","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2010.10.017_b0175","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/72785","article-title":"Aberrant CpG-island methylation has non-random and tumour-type-specific patterns","volume":"24","author":"Costello","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2010.10.017_b0180","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/oem.58.3.145","article-title":"Relation between exposure to asbestos and smoking jointly and the risk of lung cancer","volume":"58","author":"Lee","year":"2001","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.canlet.2010.10.017_b0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.lungcan.2006.12.007","article-title":"Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer","volume":"56","author":"Wang","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0190","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.1378\/chest.07-1347","article-title":"Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines","volume":"132","author":"Alberg","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.canlet.2010.10.017_b0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lungcan.2006.11.016","article-title":"Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine","volume":"56","author":"Fischer","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2007.04.008","article-title":"Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population","volume":"58","author":"Kim","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0205","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2006.03.020","article-title":"Application of a methylation gene panel by quantitative PCR for lung cancers","volume":"247","author":"Shivapurkar","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2010.10.017_b0210","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/jnci\/92.18.1511","article-title":"Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer","volume":"92","author":"Tang","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2010.10.017_b0215","first-page":"2072","article-title":"Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity","volume":"62","author":"Gasco","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0220","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejca.2005.02.020","article-title":"CpG island methylation and expression of tumour-associated genes in lung carcinoma","volume":"41","author":"Dammann","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2010.10.017_b0230","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1200\/JCO.2000.18.18.3221","article-title":"Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers","volume":"18","author":"Kersting","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2010.10.017_b0235","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/cncr.20144","article-title":"Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma","volume":"100","author":"Maruyama","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0240","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","article-title":"Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents","volume":"343","author":"Esteller","year":"2000","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2010.10.017_b0245","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/ijc.24896","article-title":"PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients","volume":"126","author":"Buckingham","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0250","first-page":"3669","article-title":"Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer","volume":"8","author":"Chang","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0255","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/cncr.23001","article-title":"Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma","volume":"110","author":"Hsu","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0260","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/path.2246","article-title":"Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment","volume":"213","author":"Hsu","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2010.10.017_b0265","first-page":"4894","article-title":"Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering","volume":"60","author":"Girard","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0270","first-page":"3743","article-title":"Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0275","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2007.10.144","article-title":"Epigenetic silencing of human T (Brachyury homologue) gene in non-small-cell lung cancer","volume":"365","author":"Park","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2010.10.017_b0280","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1038\/sj.onc.1204469","article-title":"The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas","volume":"20","author":"Dammann","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2010.10.017_b0285","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-5223(99)70192-3","article-title":"Independent prognostic role of p16 expression in lung cancer","volume":"118","author":"Groeger","year":"1999","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.canlet.2010.10.017_b0290","first-page":"1998","article-title":"Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas","volume":"7","author":"Virmani","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0295","first-page":"249","article-title":"Aberrant promoter methylation of multiple genes in non-small cell lung cancers","volume":"61","author":"Zochbauer-Muller","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0300","first-page":"3419","article-title":"p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer","volume":"61","author":"Kim","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0305","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1349-7006.2002.tb01212.x","article-title":"Frequent epigenetic silencing of the p16 gene in non-small cell lung cancers of tobacco smokers","volume":"93","author":"Yanagawa","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0310","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.10787","article-title":"Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer","volume":"103","author":"Toyooka","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0315","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","article-title":"Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world","volume":"24","author":"Kamangar","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2010.10.017_b0320","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00000658-200109000-00010","article-title":"Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the Western world","volume":"234","author":"Siewert","year":"2001","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2010.10.017_b0325","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ijc.2910580211","article-title":"Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history","volume":"58","author":"Morita","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0330","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.3748\/wjg.v10.i22.3365","article-title":"Proteomic analysis of blood level of proteins before and after operation in patients with esophageal squamous cell carcinoma at high-incidence area in Henan Province","volume":"10","author":"An","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2010.10.017_b0335","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijc.20500","article-title":"p53 Mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis","volume":"113","author":"Ito","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0340","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00595-004-2885-3","article-title":"Genetic alterations in esophageal cancer","volume":"35","author":"Kuwano","year":"2005","journal-title":"Surg. Today"},{"key":"10.1016\/j.canlet.2010.10.017_b0345","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2007.07.018","article-title":"Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage","volume":"257","author":"Lo","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2010.10.017_b0350","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1442-2050.2005.00501.x","article-title":"RASSF1A gene promoter methylation in esophageal cancer specimens","volume":"18","author":"Yamaguchi","year":"2005","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.canlet.2010.10.017_b0355","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2005.01.012","article-title":"5-Aza-2\u2032-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells","volume":"230","author":"Liu","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2010.10.017_b0360","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1442-2050.2007.00808.x","article-title":"Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma","volume":"21","author":"Zhao","year":"2008","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.canlet.2010.10.017_b0365","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1038\/sj.onc.1208598","article-title":"Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett\u2019s-associated neoplastic progression and predicts progression risk","volume":"24","author":"Schulmann","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2010.10.017_b0370","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.3748\/wjg.v12.i43.6933","article-title":"Methylation in esophageal carcinogenesis","volume":"12","author":"Wu","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2010.10.017_b0375","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/jnci\/92.22.1805","article-title":"Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma","volume":"92","author":"Kawakami","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2010.10.017_b0380","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/ijc.23804","article-title":"Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors","volume":"123","author":"Jin","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0385","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2004.06.025","article-title":"p16 Expression in Barrett\u2019s esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations","volume":"217","author":"Hardie","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2010.10.017_b0390","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1158\/1055-9965.EPI-04-0506","article-title":"Frequent methylation of eyes absent 4 gene in Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"14","author":"Zou","year":"2005","journal-title":"Cancer Epidemiol. Biomar. Prev."},{"key":"10.1016\/j.canlet.2010.10.017_b0395","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3892\/or_00000325","article-title":"Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma","volume":"21","author":"Tsunoda","year":"2009","journal-title":"Oncol Rep."},{"key":"10.1016\/j.canlet.2010.10.017_b0400","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1038\/sj.onc.1208376","article-title":"Sequential 5-aza 2\u2032-deoxycytidine\/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells","volume":"24","author":"Steiner","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2010.10.017_b0405","first-page":"3410","article-title":"Epigenetic patterns in the progression of esophageal adenocarcinoma","volume":"61","author":"Eads","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0410","first-page":"5257","article-title":"Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma","volume":"9","author":"Wang","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0415","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/carcin\/23.10.1713","article-title":"Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma","volume":"23","author":"Nie","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2010.10.017_b0420","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0003-4975(00)01140-1","article-title":"Prognostic relevance of Masaoka and Muller\u2013Hermelink classification in patients with thymic tumors","volume":"69","author":"Lardinois","year":"2000","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.canlet.2010.10.017_b0425","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/1097-0142(19940715)74:2<606::AID-CNCR2820740212>3.0.CO;2-T","article-title":"Thymoma: histologic subclassification is an independent prognostic factor","volume":"74","author":"Quintanilla-Martinez","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0430","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9440(10)64536-1","article-title":"Recurrent genetic aberrations in thymoma and thymic carcinoma","volume":"157","author":"Zettl","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2010.10.017_b0435","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.lungcan.2008.07.015","article-title":"Aberrant methylation of tumour-related genes in thymic epithelial tumours","volume":"64","author":"Hirose","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0440","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg816","article-title":"The fundamental role of epigenetic events in cancer","volume":"3","author":"Jones","year":"2002","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2010.10.017_b0445","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/1055-9965.EPI-06-0636","article-title":"Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma","volume":"16","author":"Hsiung","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.canlet.2010.10.017_b0450","first-page":"138","article-title":"DNA hypomethylation and human diseases","volume":"1775","author":"Wilson","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2010.10.017_b0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(08)60678-8","article-title":"5-Methylcytosine, gene regulation, and cancer","volume":"40","author":"Riggs","year":"1983","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0460","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/301089a0","article-title":"Hypomethylation distinguishes genes of some human cancers from their normal counterparts","volume":"301","author":"Feinberg","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2010.10.017_b0465","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.1083558","article-title":"Induction of tumors in mice by genomic hypomethylation","volume":"300","author":"Gaudet","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.canlet.2010.10.017_b0470","first-page":"445","article-title":"Three distinct regions involved in 3p deletion in human lung cancer","volume":"7","author":"Hibi","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2010.10.017_b0475","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1158\/1078-0432.CCR-09-2819","article-title":"Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer","volume":"16","author":"Saito","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0480","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/epi.09.33","article-title":"DNA hypomethylation in cancer cells","volume":"1","author":"Ehrlich","year":"2009","journal-title":"Epigenomics"},{"key":"10.1016\/j.canlet.2010.10.017_b0485","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/hupa.2001.26471","article-title":"Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression","volume":"32","author":"Piyathilake","year":"2001","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2010.10.017_b0490","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1022573630082","article-title":"Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States)","volume":"14","author":"Piyathilake","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canlet.2010.10.017_b0495","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1038\/sj.onc.1204339","article-title":"DNA methylation, chromatin inheritance, and cancer","volume":"20","author":"Rountree","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2010.10.017_b0500","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/cncr.22087","article-title":"Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer","volume":"107","author":"Kim","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0505","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/cncr.21278","article-title":"DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma","volume":"104","author":"Shieh","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0510","first-page":"4415","article-title":"Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas","volume":"9","author":"Girault","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0515","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.lungcan.2006.10.022","article-title":"Alteration of DNA methyltransferases contributes to 5\u2032CpG methylation and poor prognosis in lung cancer","volume":"55","author":"Lin","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0520","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3816\/CLC.2006.n.031","article-title":"DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value","volume":"8","author":"Vallbohmer","year":"2006","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0525","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jtcvs.2005.05.022","article-title":"Depletion of DNA methyltransferase 1 and\/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells","volume":"131","author":"Kassis","year":"2006","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.canlet.2010.10.017_b0530","first-page":"7025","article-title":"Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells","volume":"61","author":"Yang","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0535","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/CAD.0b013e3282a215e9","article-title":"Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells","volume":"18","author":"Lin","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.canlet.2010.10.017_b0540","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0959-437X(99)80026-4","article-title":"Histone acetylation and cancer","volume":"9","author":"Archer","year":"1999","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.canlet.2010.10.017_b0545","article-title":"5-Azacytidine in myelodysplastic syndromes: a clinical practice guideline","author":"Buckstein","year":"2010","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.canlet.2010.10.017_b0550","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-03-274753","article-title":"Phase II study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy","author":"Kantarjian","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2010.10.017_b0555","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2006.06.017","article-title":"Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma","volume":"54","author":"Fischer","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0560","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1158\/1078-0432.CCR-05-2858","article-title":"Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus","volume":"12","author":"Guo","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0565","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1442-2050.2008.00862.x","article-title":"Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus","volume":"22","author":"Kim","year":"2009","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.canlet.2010.10.017_b0570","first-page":"3345","article-title":"Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma","volume":"27","author":"Ito","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0575","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.cdd.4401157","article-title":"Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation","volume":"10","author":"Hopkins-Donaldson","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2010.10.017_b0580","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1245\/s10434-009-0356-1","article-title":"Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer","volume":"16","author":"Brabender","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.canlet.2010.10.017_b0585","first-page":"1441","article-title":"Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma","volume":"9","author":"Kuroki","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0590","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.humpath.2005.05.006","article-title":"PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration","volume":"36","author":"Marsit","year":"2005","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2010.10.017_b0595","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1158\/1078-0432.CCR-05-2694","article-title":"Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer","volume":"13","author":"Lee","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2010.10.017_b0600","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/gut.2006.111633","article-title":"Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett\u2019s adenocarcinoma","volume":"56","author":"Tischoff","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2010.10.017_b0605","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-3835(02)00740-1","article-title":"Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients","volume":"193","author":"Ramirez","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2010.10.017_b0610","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.11206","article-title":"Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer","volume":"106","author":"Virmani","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0615","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lungcan.2008.04.019","article-title":"Immunohistochemical diagnosis of methylthioadenosine phosphorylase (MTAP) deficiency in non-small cell lung carcinoma","volume":"63","author":"Watanabe","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canlet.2010.10.017_b0620","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/carcin\/24.1.47","article-title":"Frequent hypermethylation of the 5\u2032 CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer","volume":"24","author":"Corn","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2010.10.017_b0625","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/carcin\/23.10.1695","article-title":"Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer","volume":"23","author":"Shibata","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2010.10.017_b0630","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/carcin\/22.10.1615","article-title":"DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas","volume":"22","author":"Nie","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2010.10.017_b0635","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2004.10.041","article-title":"Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer","volume":"225","author":"Ito","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2010.10.017_b0640","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2005.03.036","article-title":"Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas","volume":"234","author":"Yi Lo","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2010.10.017_b0645","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.canlet.2008.08.021","article-title":"EMP3 as a tumor suppressor gene for esophageal squamous cell carcinoma","volume":"274","author":"Fumoto","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2010.10.017_b0650","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bbrc.2006.06.101","article-title":"Reduced expression of the Tslc1 gene and its aberrant DNA methylation in rat lung tumors","volume":"347","author":"Shimizu","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383510005021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383510005021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T10:47:09Z","timestamp":1711968429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383510005021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0304383510005021"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2010.10.017","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}